Skip to main content
Clinical Trials/CTRI/2022/05/042504
CTRI/2022/05/042504Not yet recruitingPhase 2

Comparative clinical study of efficacy of shrish twaka ghrita application with clobetasole ointment (clobetasole propionate) in management of charmadala in children with special reference to atopic dermatitis.

Dr Deepesh Naik0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 2
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • •Patient having classical signs and symptoms of charmadala.

Exclusion Criteria

  • •1]patient having any other type of kshudrakushtha or mahakushtha other than charmadala.
  • •2]patients with complications of wheeping of affected part or infected lesions.
  • •3]patient having other associated illness like diarhoea, acute respiratory infections and acute febrile or other disorders are excluded from the study.
  • •4]patient with sever form of other systemic and metabolic disorders.
  • •5]HIV ad HbSAg positive patients.
  • •6]allergic reactions to systemic/topical study drugs

Investigators

Sponsor
Dr Deepesh Naik

Similar Trials